Michael A. Levine – författare
Visar alla böcker från författaren Michael A. Levine. Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
2 180 kr
Skickas inom 7-10 vardagar
The third edition of The Parathyroids, led by a new stellar editorial team,�has been�thoroughly updated to reflect the considerable advances in just about every aspect of PTH biology over the past decade. It continues to be the authoritative reference that spans the basic science of parathyroid hormone treatment to major clinical disorders in a superb, single compendium. This translational resource is invaluable to graduate students, fellows, researchers, and research clinicians in the fields of endocrinology, bone biology, osteology, and rheumatology.
Contains chapters and information on noninvasive imaging, fracture healing, secondary diseases such as CKD, Vitamin D, cell signaling pathways, vascular calcification, as well as advances in genetics/genomics Includes essential updates on the critical importance of Vitamin D insufficiency and its relationship to secondary hyperparathyroidism Offers new insights into the underlying mechanisms of parathyroid hormone actions on osteocytes and sclerostin Examines essential updates in the understanding of secondary hyperparathyroidism associated with chronic kidney disease, facture healing, and vascular diseaseHypoparathyroidism, An Issue of Endocrinology and Metabolism Clinics of North America
Inbunden, Engelska, 2018
1 226 kr
Skickas inom 7-10 vardagar
This issue of Endocrinology and Metabolism Clinics, edited by Dr. Michael A. Levine, will focus on Hypoparathyroidism. Topics include, but are not limited to, Signs and symptoms of hypoparathyroidism, Embryology of the parathyroid glands, Physiology of parathyroid hormone, Epidemiology of hypoparathyroidism, Surgical hypoparathyroidism, Medical hypoparathyroidism, Genetic disorders of parathyroid development and function, Autoimmune hypoparathyroidism, Skeletal Manifestations of hypoparathyroidism, Renal manifestations of hypoparathyroidism, Quality of life and other targets of hypoparathyroidism, Pseudohypoparathyroidism, Conventional treatment of hypoparathyroidism, and New Directions in Treatment.